The duration of hospitalization before the bacteremia was not a risk factor. Mortality was similar in \\{ESBL\\} and non-ESBL and inadequate therapy was not shown to be a risk factor. Conclusion ESBL-producing Klebsiella bacteremia can occur early, suggesting that a carbapenem should be ...
2011. The effect of inap- propriate therapy on bacteremia by ESBL-producing bacteria. Infection 39:555-561.De Rosa FG, Pagani N, Fossati L, et al. The effect of inappropriate therapy on bacteremia by ESBL-pro- ducing bacteria. Infection 2011; 39: 555-61....
The only independent risk factor for MDR ESBL EK was duration of hospitalization before bacteraemia (OR 3.88; 95% CI 1.55 9.71; p=0.004). The rate of multidrug resistance among ESBL-EK bloodstream isolates was high, and duration of hospitalization before bacteraemia was the only indeepended ...
Emphasis on Antimicrobial Therapy. AAC. 2004, 48,(12),p. 4574–4581 存活率 28 产E S B L s 菌 株血行 感染: 不同抗 菌药物 经验性 治疗疗 效比较 不 . CRAB 是21 世纪的耐药哨兵事 件,是21 世纪的MRSA % year • 耐药性(CHINET 数据;不动杆菌) ...
650: USE OF NON-CARBAPENEM ANTIBIOTICS AS DEFINITIVE THERAPY FOR ESBL BACTEREMIAdoi:10.1097/01.ccm.0000551402.93489.4eDiana GritsenkoSamad TirmiziSteven LemieuxDayna McManusJeffrey TopalCritical Care Medicine
of Peptide Variants with Antimicrobial, Anti-Biofilm, or Anti-Inflammatory EffectsActivity of Novel Antimicrobials against Gram-Negative Clinical Pathogens and Characterization of Their Resistance MechanismsAdaptive Evolution of Bacterial Pathogens in Response to Antibiotic TherapyAdvances in Orthopedic Infection ...